Chiesi USA, Inc.
Cornerstone Therapeutics Inc. is a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the hospital, niche respiratory and related markets. The company currently promotes CUROSURF® (poractant alfa) Intratracheal Suspension and Cardene® I.V. (nicardipine hydrochloride) in the U.S. For information please visit www.crtx.com.
1255 Crescent Green Drive